John B Haanen Selected Research

John B Haanen Research Topics

Disease

33	Melanoma (Melanoma, Malignant) 04/2024 - 07/2009
28	Neoplasms (Cancer) 01/2023 - 10/2008
8	Renal Cell Carcinoma (Grawitz Tumor) 11/2020 - 11/2010
4	Neoplasm Metastasis (Metastasis) 04/2024 - 09/2015
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2016
3	Exanthema (Rash) 03/2014 - 06/2011
2	Brain Neoplasms (Brain Tumor) 05/2023 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 01/2023 - 01/2020
2	Uveitis 07/2022 - 12/2013
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 01/2019
2	Inflammation (Inflammations) 03/2019 - 09/2009
2	Disease Progression 07/2015 - 06/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2014 - 06/2011
2	Keratoacanthoma 03/2014 - 06/2011
2	Diarrhea 02/2013 - 06/2011
1	COVID-19 10/2022
1	Death (Near-Death Experience) 10/2022
1	Retinal Detachment (Retinal Detachments) 07/2022
1	Panuveitis 07/2022
1	Papilledema 07/2022
1	Pain (Aches) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2020
1	Kidney Neoplasms (Kidney Cancer) 10/2019
1	Neutropenia 03/2014
1	Pruritus (Itching) 02/2013
1	Carcinoma (Carcinomatosis) 07/2011
1	Nausea 06/2011
1	Fatigue 06/2011
1	Alopecia (Baldness) 06/2011
1	Arthralgia (Joint Pain) 06/2011
1	Body Weight (Weight, Body) 08/2010

Drug/Important Bio-Agent (IBA)

10	Immune Checkpoint InhibitorsIBA 05/2023 - 01/2019
10	IpilimumabIBA 01/2023 - 08/2010
7	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2024 - 01/2018
5	VaccinesIBA 04/2024 - 07/2011
5	NivolumabIBA 01/2023 - 07/2015
5	VemurafenibIBA 01/2018 - 06/2011
4	Sunitinib (Sutent)FDA Link 11/2020 - 09/2009
3	pembrolizumabIBA 07/2022 - 10/2015
3	LigandsIBA 11/2020 - 08/2010
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 10/2012
3	enzalutamideIBA 01/2020 - 01/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2019 - 11/2011
3	Everolimus FDA Link 03/2019 - 11/2011
3	Dacarbazine (DIC)FDA LinkGeneric 03/2014 - 06/2011
2	mRNA VaccinesIBA 04/2024 - 10/2022
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 07/2009
2	Radium-223IBA 01/2022 - 01/2020
2	AntibodiesIBA 01/2021 - 08/2010
2	abirateroneIBA 01/2020 - 01/2016
2	Docetaxel (Taxotere)FDA Link 01/2020 - 01/2016
2	Tyrosine Kinase InhibitorsIBA 10/2019 - 11/2011
2	AntigensIBA 01/2019 - 07/2009
2	CTLA-4 AntigenIBA 07/2015 - 08/2010
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2023
1	Cancer VaccinesIBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	A-factor (Streptomyces)IBA 09/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2022
1	SteroidsIBA 07/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	RadiopharmaceuticalsIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	talimogene laherparepvecIBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	Axitinib (AG 013736)IBA 11/2020
1	avelumabIBA 11/2020
1	RNA (Ribonucleic Acid)IBA 06/2020
1	Celecoxib (Celebrex)FDA Link 01/2020
1	cabazitaxel FDA Link 01/2020
1	Transcription Factors (Transcription Factor)IBA 03/2019
1	MTOR InhibitorsIBA 02/2019
1	AutoantibodiesIBA 01/2019
1	Immune Checkpoint ProteinsIBA 12/2018
1	cyclic adenosine-5'-trimetaphosphate (ATMP)IBA 11/2018
1	dabrafenibIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2016
1	Peptides (Polypeptides)IBA 09/2014
1	EpitopesIBA 09/2014
1	Monoclonal AntibodiesIBA 02/2013
1	Temozolomide (Temodar)FDA LinkGeneric 02/2013
1	tremelimumabIBA 02/2013
1	DNA VaccinesIBA 12/2012
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 10/2012
1	Amyloid (Amyloid Fibrils)IBA 10/2012
1	TOR Serine-Threonine KinasesIBA 11/2011
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2011
1	DNA (Deoxyribonucleic Acid)IBA 07/2011
1	Proto-Oncogene Proteins B-rafIBA 06/2011
1	HLA-A*02:01 antigenIBA 08/2010
1	Protein Subunit VaccinesIBA 08/2010

Therapy/Procedure

21	Therapeutics 03/2023 - 08/2010
10	Immunotherapy 01/2023 - 10/2008
4	Castration 01/2022 - 01/2016
1	Injections 07/2022
1	Nephrectomy 10/2019
1	Radiotherapy 01/2018
1	Drug Therapy (Chemotherapy) 02/2013